[1]
|
A. Liekweg, M. Westfeld and U. Jaehde, “From Oncology Pharmacy to Pharmaceutical Care: New Contributions to Multidisciplinary Cancer Care,” Supplementary Care in Cancer, Vol. 12, No. 2, 2004, pp. 73-79.
doi:10.1007/s00520-003-0539-4
|
[2]
|
M. Werle, A. Makhlof and H. Takeuchi, “Oral Protein Delivery: A Patent Review of Academic and Industrial Approaches,” Recent Patent in Drug Delivery Formulations, Vol. 3, No. 2, 2009, pp. 94-104.
doi:10.2174/187221109788452221
|
[3]
|
D. K. Pettit and W. R. Gombotz, “The Development of Site-Specific Drug-Delivery Systems for Protein and Peptide Biopharmaceuticals,” Trends in Biotechnology, Vol. 16, No. 8, 1998, pp. 343-349.
doi:10.1016/S0167-7799(98)01186-X
|
[4]
|
J. K. Oh, R. Drumright, D. Siegwart and K. Maty-jaszewski, “The Development of Microgels/Nanogels for Drug Delivery Applications,” Progress in Polymer Science, Vol. 33, No. 4, 2008, pp. 448-477.
doi:10.1016/j.progpolymsci.2008.01.002
|
[5]
|
K. K. Peh and C. F. Wong, “Polymeric Films as Vehicle for Buccal Delivery: Swelling, Mechanical, and Bioadhesive Properties,” Journal of Pharmacy and Pharmaceutical Science, Vol. 2, 1999, pp. 53-61.
|
[6]
|
J. S. Boateng, A. D. Auffret, K. H. Matthews, M. J. Humphrey, H. N. E. Stevens and G. M. Eccleston, “Characterization of Freeze-Dried Wafers and Solvent Evaporated Films as Potential Drug Delivery Systems to Mucosal Surfaces,” International Journal of Pharmaceutics, Vol. 389, No. 1-2, 2010, pp. 24-31.
doi:10.1016/j.ijpharm.2010.01.008
|
[7]
|
N. Salamat-Miller, M. Chittchang and T. P. Johnston, “The Use of Mucoadhesive Polymers in Buccal Drug Delivery,” Advanced Drug Delivery Reviews, Vol. 57, No. 11, 2005, pp. 1666-1691.
doi:10.1016/j.addr.2005.07.003
|
[8]
|
S. I. Pather, M. J. Rathbone and S. Senel, “Current Status and the Future of Buccal Drug Delivery Systems,” Expert Opinions in Drug Delivery, Vol. 5, No. 5, 2008, pp. 531- 542. doi:10.1517/17425247.5.5.531
|
[9]
|
B. Baert, E. Deconinck, M. Van Gele, M. Slodicka, P. Stoppie, S. Bodé, G. Slegers, Y. Vander Heyden, J. Lambert, J. Beetens and B. De Spiegeleer, “Transdermal Penetration Behavior of Drugs: CART-Clustering, QSPR and Selection of Model Compounds,” Bioorganic Medicinal Chemistry, Vol. 15, No. 22, 2007, pp. 6943-6455.
doi:10.1016/j.bmc.2007.07.050
|
[10]
|
Y. Yuguchi, T. Thuy, H. Urakawa and K. Kajiwara, “Structural Characteristics of Carrageenan Gels: Temperature and Concentration Dependence,” Food Hydrocolloids, Vol. 16, No. 6, 2002, pp. 515-522.
doi:10.1016/S0268-005X(01)00131-X
|
[11]
|
O. Tari, S. Kara and O. Pekcan, “Critical Exponents of Kappa Carrageenan in the Coil-Helix and Helix-Coil Hysteresis Loops,” Journal of Macromolecular Science Part B-Physics, Vol. 48, No. 4, 2009, pp. 812-822.
doi:10.1080/00222340902956129
|
[12]
|
M. Thommes and P. Kleinebudde, “Use of Kappa-Carrageenan as Alternative Pelletisation Aid to Microcrystalline Cellulose in Extrusion/Spheronization. II. Influence of Drug and Filler Type,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 63, No. 1, 2006. pp. 68-75. doi:10.1016/j.ejpb.2005.10.003
|
[13]
|
Y. Liu, W. L. Lu, H. C. Wang, X. Zhang, H. Zhang, X. Q. Wang, T. Y. Zhou and Q. Zhang, “Controlled Delivery of Recombinant Hirudin Based on Thermo-Sensitive Pluronic (R) F127 Hydrogel for Subcutaneous Administration: In Vitro and in Vivo Characterization,” Journal of Controlled Release, Vol. 117, No. 3, 2007, pp. 387-395.
doi:10.1016/j.jconrel.2006.11.024
|
[14]
|
A. Paavola, J. Yliruusi and P. Rosenberg, “Controlled Release and Dura Mater Permeability of Lidocaine and Ibuprofen from Injectable Poloxamer-Based Gels,” Journal of Controlled Release, Vol. 52, No. 1-2, 1998, pp. 169-178. doi:10.1016/S0168-3659(97)00206-X
|
[15]
|
G. G .Z. Zhang, D. Law, E. A. Schmitt and Y. H. Qiu, “Phase Transformation Considerations during Process Development and Manufacture of Solid Oral Dosage Forms,” Advanced Drug Delivery Reviews, Vol. 56, No. 3, 2004, pp. 371-390. doi:10.1016/j.addr.2003.10.009
|
[16]
|
F. Tirnaksiz and J. R. Robinson, “Rheological, Mucoad-hesive and Release Properties of Pluronic F-127 Gel and Pluronic F-127/Polycarbophil Mixed Gel Systems,” Pharmazie, Vol. 60, No. 7, 2005, pp. 518-523.
|
[17]
|
H. Sohi, A. Ahuja, F. Jalees Ahmad and R. Krishen Khar, “Critical Evaluation of Permeation Enhancers for Oral Mucosal Drug Delivery,” Drug Development and Industrial Pharmacy, Vol. 36, No. 3, 2010, pp. 254-282.
doi:10.3109/03639040903117348
|
[18]
|
D. Q. M. Craig, “A Review of Thermal Methods Used for the Analysis of the Crystal Form, Solution Thermodynamics and Glass-Transition Behavior of Polyethylene Glycols,” Thermochimica Acta, Vol. 248, 1995, pp. 189- 203. doi:10.1016/0040-6031(94)01886-L
|
[19]
|
J. S. Boateng, H. N. E. Stevens, G. M. Eccleston, A. D. Auffret, M. J. Humphrey and K. H. Matthews, “Development and Mechanical Characterization of Solvent-Cast Polymeric Films as Potential Drug Delivery Systems to Mucosal Surfaces,” Drug Development and Industrial Pharmacy, Vol. 35, No. 8, 2009, pp. 986-996.
doi:10.1080/03639040902744704
|
[20]
|
K. Huynh-Ba, “Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies, and Best Practices,” Springer, 2009, pp. 248-250.
doi:10.1007/978-0-387-85627-8
|
[21]
|
G. Wypych, “Handbook of Plasticizers,” ChemTec, 2004, pp. 218-220.
|
[22]
|
B. C. Hancock and M. Parks, “What Is the True Solubility Advantage for Amorphous Pharmaceuticals?” Pharmaceutical Research, Vol. 17, No. 4, 2000, pp. 397-404.
doi:10.1023/A:1007516718048
|
[23]
|
L. Yu, “Amorphous pharmaceutical Solids: Preparation, Characterization and Stabilization,” Advanced Drug Delivery Reviews, Vol. 48, No. 1, 2001, pp. 27-42.
doi:10.1016/S0169-409X(01)00098-9
|
[24]
|
O. K. C. Tsui, T. P. Russel and C. J. Hawker, “Effect of Polymer-Substrate Interactions on the Glass Transition of Polymer Thin Films,” 3rd International Symposium on Slow Dynamics in Complex Systems, Proceedings AIP Conference, Vol. 708, 2004, pp. 598-600.
|
[25]
|
S. Farmer, P. Anderson, P. Burns and R. Velagaleti, “Forced Degradation of Ibuprofen in Bulk Drug and Tablets,” Pharmaceutical Technology, Vol. 32, 2002, pp. 28-42.
|
[26]
|
W. C. Cory, C. Harris and S. Martinez, “Accelerated Degradation of Ibuprofen in Tablets,” Pharmaceutical Development and Technology, Vol. 15, No. 6, 2010, pp. 636-643. doi:10.3109/10837450903426518
|
[27]
|
J. S. Boateng, K. H. Matthews, A. D. Auffret, M. J. Humphrey, H. N. E. Stevens and G. M. Eccleston, “In Vitro Drug Release Studies of Polymeric Freeze-Dried Wafers and Solvent-Cast Films Using Paracetamol as a Model Soluble Drug,” International Journal of Pharmaceutics, Vol. 378, No. 1-2, 2009, pp. 66-72.
doi:10.1016/j.ijpharm.2009.05.038
|
[28]
|
J. Siepmann and N. A. Peppas, “Modeling of Drug Release from Delivery Systems Based on Hydroxypropyl-methylcellulose (HPMC),” Advanced Drug Delivery Reviews, Vol. 48, No. 2-3, 2001, pp. 139-157.
doi:10.1016/S0169-409X(01)00112-0
|